---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-005453"
form_type: "8-K"
ticker: "NXL"
cik: "0001527352"
company_name: "Nexalin Technology, Inc."
filed_at: "2026-05-19T20:00:16+00:00"
generated_at: "2026-05-19T20:02:47.906241+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nexalin acquires PONM digital health platform for HALO Clarity for $1.3M in stock

## Summary
- Acquisition of all PONM shares for $1.3M in Nexalin common stock; first tranche of 959,016 shares issued at closing.
- PONM platform, already deployed at UCSD, supports AI-integrated remote monitoring, EHR, and virtual-clinic workflows.
- Planned 160-participant FDA pivotal trial for HALO Clarity in moderate-to-severe insomnia; enrollment expected Q2 2026.
- GreenLight becomes a meaningful equity holder and enters strategic partnership for development, regulatory, and commercial support.
- Collaboration Agreement with GLV provides ongoing development services at $10,000/month for 24-month initial term.

## SEC filing metadata
- accession: 0001829126-26-005453
- form_type: 8-K
- ticker: NXL
- cik: 0001527352
- company_name: Nexalin Technology, Inc.
- filed_at: 2026-05-19T20:00:16+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/0001829126-26-005453-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/nexalintec_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-005453
- JSON: https://secwatch.observer/filing/0001829126-26-005453.json
- Plain text: https://secwatch.observer/filing/0001829126-26-005453.txt

## Key facts
- Material Agreements
  Nexalin Technology, Inc. entered into Stock Purchase Agreement with GreenLight Ventures LLC valued at 1,300,000 (effective 2026-05-14).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: GreenLight Ventures LLC
  - Value: 1,300,000
  - Effective: 2026-05-14
  source text: On May 14, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GreenLight Ventures LLC, a North Carolina limited liability company (“GLV”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/0001829126-26-005453-index.htm
- Material Agreements
  Nexalin Technology, Inc. entered into Collaboration Agreement with GreenLight Ventures LLC valued at 10,000 per month (effective 2026-05-14).
  - Action: entry
  - Agreement: collaboration
  - Counterparty: GreenLight Ventures LLC
  - Value: 10,000 per month
  - Effective: 2026-05-14
  source text: On May 14, 2026, the Company entered into a Collaboration Agreement (the “Collaboration Agreement”) with GLV to support the development, compliance and commercialization of the Company’s cranial electrotherapy stimulation technologies and related products using certain licensed software associated with GLV’s digital technology platforms.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/0001829126-26-005453-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.